Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma. [electronic resource]
Producer: 20171212Description: 1330-1336 p. digitalISSN:- 1476-5365
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bendamustine Hydrochloride -- administration & dosage
- Dexamethasone -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Hematopoietic Stem Cell Mobilization -- adverse effects
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- therapy
- Peripheral Blood Stem Cell Transplantation -- methods
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.